Songmin Ying | Immunology | Best Researcher Award

Prof. Dr. Songmin Ying | Immunology | Best Researcher Award

MD, PhD at Zhejiang University, China

Songmin Ying is a Qiushi Distinguished Professor and Doctoral Supervisor at Zhejiang University School of Medicine. He serves as the Executive Dean and Director of the Zhejiang-Denmark Joint Laboratory for Regenerative and Aging Medicine. His research focuses on chronic airway diseases, aging medicine, and pharmacology. Dr. Ying has held various prestigious academic and research positions, including at the University of Oxford and the Technical University of Munich. With an extensive publication record in high-impact journals, he has significantly contributed to immunology, oncology, and respiratory medicine. His pioneering research has garnered numerous accolades, cementing his reputation as a leader in biomedical sciences.

Professional Profiles📖

Google Scholar

Education 🎓

Dr. Ying’s academic journey began at Shantou University School of Medicine, where he earned his Bachelor’s degree in Clinical Medicine (2003-2007). He then pursued a Master’s in Molecular Genetic Medicine at the University of Sheffield (2007-2010), followed by a Doctorate in Biochemistry at the Technical University of Munich (2010-2013). His postdoctoral training took place at the University of Oxford in the Department of Oncology and the Weatherall Institute of Molecular Medicine. This diverse and prestigious academic background has equipped him with expertise in molecular medicine, respiratory diseases, and translational pharmacology.

Work Experience💼

Dr. Ying’s career is marked by leadership roles in medical research and academia. He has been a Research Fellow and Professor at the Institute of Respiratory Diseases, Zhejiang University, since 2013. In 2023, he was appointed Executive Dean of Zhejiang University School of Medicine, where he oversees groundbreaking biomedical research. His role as Director of the Zhejiang-Denmark Joint Laboratory for Regenerative and Aging Medicine reflects his global research collaborations. His extensive international experience includes significant contributions at the University of Oxford and other renowned institutions.

Awards and Honors 🏆

Dr. Ying has received numerous awards for his contributions to medical research, particularly in immunology and respiratory diseases. He has been recognized with the Qiushi Distinguished Professorship, Zhejiang University’s highest honor. His research has also earned prestigious grants and fellowships, reflecting his impact on aging medicine and airway disease research. He has been invited as a keynote speaker at leading medical conferences worldwide, further solidifying his influence in the scientific community.

Skills💡

Dr. Ying possesses expertise in molecular biology, immunology, pharmacology, and respiratory medicine. His skills include high-throughput sequencing, CRISPR gene editing, and advanced imaging techniques. He is also proficient in bioinformatics analysis and translational medicine strategies. As an academic leader, he has extensive experience in mentoring PhD students and leading multidisciplinary research teams. His collaboration with international institutions enhances his ability to drive innovation in medical sciences.

Research Focus 🔬

Dr. Ying’s research centers on chronic airway diseases, aging medicine, and pharmacology. His work explores the molecular mechanisms of immune responses in respiratory disorders, with an emphasis on eosinophilic inflammation and metabolic adaptation in allergic diseases. He investigates aging-related pathologies and regenerative medicine, aiming to develop targeted therapies for age-associated respiratory diseases. His interdisciplinary approach integrates genomics, bioinformatics, and experimental medicine, positioning his work at the forefront of translational research.

Conclusion✅

Professor Songmin Ying is highly deserving of the Best Researcher Award due to his exceptional research output, leadership, and impact on biomedical sciences. His contributions to chronic diseases, immunology, and aging medicine are globally recognized, making him a strong contender. Further clinical applications and public engagement could enhance his influence even more.

Publications Top Notes📚

Replication stress induces sister-chromatid bridging at fragile site loci in mitosis

Citations: 674

Year: 2009

Replication stress activates DNA repair synthesis in mitosis

Citations: 571

Year: 2015

Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1

Citations: 394

Year: 2012

MUS81 promotes common fragile site expression

Citations: 281

Year: 2013

Chlamydia Inhibit Host Cell Apoptosis by Degradation of Proapoptotic BH3-only Proteins

Citations: 253

Year: 2004

Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments

Citations: 209

Year: 2018

Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury

Citations: 201

Year: 2016

Autophagy is essential for ultrafine particle-induced inflammation and mucus hyperproduction in airway epithelium

Citations: 178

Year: 2016

Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma

Citations: 170

Year: 2017

Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival

Citations: 158

Year: 2006

Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis

Citations: 140

Year: 2015

Pathological roles of neutrophil‐mediated inflammation in asthma and its potential for therapy as a target

Citations: 123

Year: 2017

Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation

Citations: 114

Year: 2020

LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension

Citations: 106

Year: 2018

MTOR suppresses cigarette smoke–induced epithelial cell death and airway inflammation in chronic obstructive pulmonary disease

Citations: 102

Year: 2018

DNA-PKcs and PARP1 bind to unresected stalled DNA replication forks where they recruit XRCC1 to mediate repair

Citations: 96

Year: 2016

Broad Degradation of Proapoptotic Proteins with the Conserved Bcl-2 Homology Domain 3 during Infection with Chlamydia trachomatis

Citations: 94

Year: 2005

ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation

Citations: 88

Year: 2021

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis

Citations: 85

Year: 2017

Autophagy plays an essential role in cigarette smoke-induced expression of MUC5AC in airway epithelium

Citations: 82

Year: 2016

Lin Zhou | Diseases | Excellence in Innovation

prof. Dr. Lin Zhou | Diseases | Excellence in Innovation

Dr  at Guangdong Pharmaceutical University, China

Lin Zhou is a distinguished professor in the Bioengineering Department at Guangdong Pharmaceutical University, China. With a strong background in carbohydrate engineering and fermentation technology, he has significantly contributed to the fields of bioactive substances, phytochemicals, and microbial metabolites. His research spans various biomedical applications, particularly in food science and chronic metabolic diseases. Having worked as a lecturer, associate professor, and professor at GDPU, he has led multiple national and industry-funded research projects. Lin Zhou’s expertise lies in antioxidant, anti-tumor, and anti-aging properties of bioactive substances. His scientific contributions are widely recognized, with numerous publications in high-impact journals. Apart from academia, he has experience in industrial fermentation engineering, reflecting his practical approach to biotechnology research. His work continues to influence advancements in pharmaceutical and food sciences, earning him prestigious awards in science and technology.

Professional Profiles📖

ORCID

Education 🎓

Ph.D. in Carbohydrate Engineering (2006) – South China University of Technology (SCUT), Guangzhou, China, under the guidance of Prof. Siyuan Guo.

Master to Ph.D. Direct Track (2001-2006) – South China University of Technology.

B.S. in Fermentation Engineering (1995-1999) – Hubei University of Technology (HBUT).

Work Experience💼

2018-2019 – Visiting Scholar, CSIRO, Melbourne, Australia.

2014-2017 – Postdoctoral Researcher, South China University of Technology.

2006-Present – Professor, Guangdong Pharmaceutical University.

2011-2012 – Scientific Special Commissioner, Guangdong Province.

2000-2001 – Workshop Manager, HeChengFeng Food and Beverage Ltd, China.

1999-2000 – Workshop Manager, ChuTe Food and Beverage Ltd, China.

Awards and Honors 🏆

First Prize in Science and Technology (2024) – Provincial High-Tech Enterprise Association, Guangdong, China.

Second Prize in Science and Technology (2024) – Provincial Light Industry Council, Guangdong, China.

Skills 💡

Bioactive Compound Analysis

Fermentation Technology

Microbial Metabolite Research

Pharmaceutical Biotechnology

Food Science and Engineering

Scientific Writing and Research Management

Innovation in Biopharmaceuticals

Research Focus 🔬

Lin Zhou specializes in the functional study of bioactive substances, emphasizing phytochemicals and microbial metabolites. His research explores the antioxidant, anti-tumor, and anti-aging potential of natural compounds, contributing to biomedical sciences. His work intersects microbiology, food science, and pharmaceuticals, leading industry-oriented research and collaborations. He has participated in China’s National Key R&D Program and led multiple industry-funded projects, making significant contributions to applied biotechnology.

Conclusion✅

Prof. Lin Zhou is a strong candidate for the Excellence in Innovation Award due to his extensive contributions to bioengineering, pharmaceutical sciences, and food biotechnology. His research has significantly advanced knowledge in metabolic disease treatment and bioactive substances, making him a worthy recipient of this recognition. Enhancing commercialization efforts and expanding global collaborations could further elevate his profile in scientific innovation.

Publications Top Notes📚

“Piggyback Crowdsensing (PCS): Energy Efficient Crowdsourcing of Mobile Sensor Data by Exploiting Smartphone App Opportunities”
Citations: 224
Year: 2013

“Cutting the Cord: A Robust Wireless Facilities Network for Data Centers”
Citations: 83
Year: 2014

“On the Validity of Geosocial Mobility Traces”
Citations: 78
Year: 2013

“Voting by Committees”
Citations: 435
Year: 1991

“On a Conjecture by Gale About One-Sided Matching Problems”
Citations: 357
Year: 1990

“A New Bargaining Set of an N-Person Game and Endogenous Coalition Formation”
Citations: 174
Year: 1994

“Atomic-Scale Characterization of Dilute Dopants in Topological Insulators via STEM–EDS Using Registration and Cell Averaging Techniques”
Year: 2024

“Sub-Lexical Phonological and Semantic Processing of Semantic Radicals: A Primed Naming Study”
Citations: 57
Year: 2013

“A Chinese Text Input Brain–Computer Interface Based on the P300 Speller”
Citations: 50
Year: 2012

“Pre-Lexical Phonological Processing in Reading Chinese Characters: An ERP Study”
Citations: 36
Year: 2014

“Measuring Megaregional Structure in the Pearl River Delta by Mobile Phone Signaling Data: A Complex Network Approach”
Citations: 76
Year: 2020

“Actors and Network in the Marketization of Rural Collectively-Owned Commercial Construction Land (RCOCCL) in China: A Pilot Case of Langfa, Beijing”
Citations: 31
Year: 2020

“Efficiency and Equality of the Multimodal Travel Between Public Transit and Bike-Sharing Accounting for Multiscale”
Citations: 10
Year: 2024